<SEC-DOCUMENT>0001493152-17-008962.txt : 20170811
<SEC-HEADER>0001493152-17-008962.hdr.sgml : 20170811
<ACCEPTANCE-DATETIME>20170811151900
ACCESSION NUMBER:		0001493152-17-008962
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170807
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170811
DATE AS OF CHANGE:		20170811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		171024702

	BUSINESS ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): August 7, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-19871</B></FONT></TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>94-3078125</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
                                         or other jurisdiction</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission
                                         </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
        Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
                                         Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
Massachusetts 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
of Principal Executive Offices) (Zip Code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant&rsquo;s
telephone number, including area code: (781) 875-3605</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.4in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.8in; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
3.02</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unregistered
    Sales of Equity Securities.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
June 19, 2017 and August 7, 2017, the holder of the Series A Convertible Preferred Stock, par value $0.01 per share (the &ldquo;Preferred
Stock&rdquo;) of Microbot Medical Inc. (the &ldquo;Company&rdquo;), converted an aggregate of 2,029 shares of the Preferred Stock
for an aggregate of 2,029,000 shares of the Company&rsquo;s common stock. Pursuant to the terms of conversion of the Preferred
Stock, each such share is convertible, upon request and for no additional consideration, into 1,000 shares of the common stock
of the Company. The issuances of the 2,029,000 shares of common stock were exempt from registration under Section 4(a)(2) under
the Securities Act of 1933, as amended and the rules promulgated thereunder (the &ldquo;Securities Act&rdquo;) as transactions
not involving a public offering to a single existing stockholder who is an accredited investor, and/or 3(a)(9) under the Securities
Act as the Preferred Stock was exchanged for common stock by an existing security holder and no commission or other remuneration
was paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.8in; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
    7.01</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
    FD Disclosure</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 10, 2017, Microbot Medical Inc. (the &ldquo;Registrant&rdquo;) issued a press release announcing that it will host an investor
briefing conference call and webcast on Monday, August 14, 2017, at 5:00 p.m., Eastern time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Item 7.01 and in Item 9.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall
not be deemed to be &ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any
information in this Item 7.01 or Item 9.01 (including Exhibit 99.1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.8in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
    9.01 </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
    Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.7in; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No. </B></FONT></TD>
    <TD STYLE="width: 0.15in; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release dated August 10, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
    MEDICAL INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 11, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 9pt Sans-Serif; margin: 0 0 0 106.2pt; text-indent: 35.4pt; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 110; width: 269">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
Immediate Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">Microbot
Medical Inc. to Report Second Quarter Results on August 14, 2017</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; letter-spacing: 0pt"><I>Conference
Call Scheduled for Monday, August 14th at 5:00pm ET</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hingham,
MA &ndash; August 10, 2017 &ndash; Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and
development of transformational micro-robotic medical technologies, will release second quarter 2017 financial and operational
results on Monday, August 14, 2017 after the close of the U.S. markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will host a conference call and webcast on Monday, August 14, 2017 at 5:00 pm ET. For both &ldquo;listen-only&rdquo; participants
and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number is 888-208-1814
(U.S./Canada) or 719-325-2154 (international) and providing the Conference ID 6914000. A live webcast and subsequent archived
replay may be accessed via the &lsquo;Investors&rsquo; section, under &lsquo;Presentations and Resources&rsquo; of the Company&rsquo;s
website at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
replay of the conference call will be available for seven business days beginning about two hours after the conclusion of the
live call, by dialing 888-203-1112 (U.S./Canada) or +1 719-457-0820 (international) and providing the Conference ID 6914000. An
archived webcast will also be available and may be accessed in the &lsquo;Investors&rsquo; section of the Company&rsquo;s website
at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Microbot Medical Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot,
which was founded in 2010 and commenced operations in 2011, became a NASDAQ listed company on November 28, 2016. The Company specializes
in transformational micro-robotic medical technologies leveraging the natural and artificial lumens within the human body. Microbot&rsquo;s
current platforms, ViRob and TipCAT, are comprised of two highly advanced micro-robotic technologies, from which the Company is
currently developing its first two product candidates: the Self Cleaning Shunt, or SCS, for the treatment of hydrocephalus and
Normal Pressure Hydrocephalus, or NPH; and a self-propelling, semi-disposable endoscope that is being developed initially for
use in colonoscopy procedures. Further information about Microbot Medical is available at http://www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ViRob technology is a revolutionary autonomous crawling micro-robot which can be controlled remotely or within the body. Its miniature
dimensions allow it to navigate and crawl in different spaces within the human body, including blood vessels, the digestive tract
and the respiratory system. Its unique structure gives it the ability to move in tight spaces and curved passages as well as the
ability to remain within the human body for prolonged time. To learn more about ViRob please visit http://www.microbotmedical.com/technology/virob/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TipCAT
is a transformational self-propelled, flexible, and semi-disposable endoscope providing see &amp; treat capabilities within tubular
lumens in the human body such as the colon, blood vessels, and the urinary tract. Its locomotion mechanism is perfectly suitable
to navigate and crawl through natural &amp; artificial tubular lumens, applying the minimal necessary pressure to achieve the
adequate friction required for gentle, fast, and safe advancement within the human body. To learn more about TipCAT visit http://www.microbotmedical.com/technology/tipcat/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EVC
Group</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Polyviou/Doug Sherk - Investors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpolyviou@evcgroup.com;
dsherk@evcgroup.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(646)
445-4800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">###</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 6T# 2(  A$! Q$!_\0
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M+12!@3@4M !11FDS0 M%)GG%+F@ HHHH **** "BBB@ HHHH **** "BBB@
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MM'\/X5XOXB'_ !.+D?[9/ZT 9D(']I6?_70']17NUK_QZQ_[HKPF'_D)6?\
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M6Q<YVC/KBE(#<$9'N*=P/,;CQ#J-[;K;P:5B;@;C#C^E:Q\-7VI^&?+OBHO
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MOB@!PQ2T@I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *, =J** "BBB@ HHH
0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
